8-Chloro-Cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells

Cancer Research

Volumn 65, Issue 11, 2005, Pages 4896-4901

  Ahn, Young Ho ^a   Jung, Joong Mok ^a   Hong, Seung Hwan ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 8 CHLOROADENOSINE 3',5' PHOSPHATE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

2-CHLOROADENOSINE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL GROWTH PROCESSES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; K562 CELLS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 19644394294     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3122     Document Type: Article

References (46)

1. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 2002;12:258-66.
2. Krebs EG, Beavo JA Phosphorylation-dephosphorylation of enzymes. Annu Rev Biochem 1979;48:923-59.
3. Maurer RA. Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 1981;294:94-7.
4. 2-dibutyryl cyclic amp increase the rate of transcription and change the stability of lactate dehydrogenase a subunit messenger RNA in rat C6 glioma cells. J Biol Chem 1983;258:5312-8.
5. +-channel activity by protein phosphorylation. Nature 1985;315:503-6.
6. Vossler MR, Yao H, York RD, et al. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rapl-dependent pathway. Cell 1997;89:73-82.
7. Yarwood SJ, Kilgour E, Anderson NG. Cyclic AMP potentiates growth hormone-dependent differentiation of 3T3-F442A preadipocytes: possible involvement of the transcription factor CREB. Mol Cell Endocrinol 1998;138:41-50.
8. Boulogne B, Habert R, Levacher C. Regulation of the proliferation of cocultured gonocytes and Sertoli cells by retinoids, triiodothyronine, and intracellular signaling factors: differences between fetal and neonatal cells. Mol Reprod Dev 2003;65:194-203.
9. Sevetson BR, Kong X, Lawrence JC Jr, Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci U S A 1993;90:10305-9.
10. Chen J, Iyengar R. Suppression of Ras-induced transformation of NIH 3T3 cells by activated Gas. Science 1994;263:1278-81.
11. Altschuler DL, Peterson SN, Ostrowski MC, et al. Cyclic AMP-dependent activation of Raplb. J Biol Chem 1995;270:10373-6.
12. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rapl guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998;396:474-7.
13. Schmitt JM, Stork PJ. Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rapl. Mol Cell Biol 2001;21:3671-83.
14. Kim SN, Ahn YH, Kim SG, et al. 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer 2001;93:33-41.
15. Cho-Chung YS. Modulation of adenylate cyclase signalling. Semin Cancer Biol 1992;3:361-7.
16. Cummings J, Fielding H, Miller WR. Pharmaceutical analysis of 8-chloroadenosine 3′, 5′-monophosphate. J Pharm Biomed Anal 1994;12:1289-94.
17. Cho-Chung YS, Clair T, Tagliaferri P, et al. Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest 1989;7:161-77.
18. Halgren RG, Traynor AE, Pillay S, et al. 8Cl-cAMP cytotoxicity in both steroid sensitive and insensitive multiple myeloma cell lines is mediated by 8Cl-adenosine. Blood 1998;92:2893-8.
19. Gandhi V, Ayres M, Halgren RG, et al. 8-Chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res 2001;61:5474-9.
20. Lamb D, Steinberg RA. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression. J Cell Physiol 2002;192:216-24.
21. Ahn YH, Jung JM. Hong SH. 8-Cl-cAMP and its metabolite, 8-Cl-adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways; protein kinase C activation and cyclin B down-regulation. J Cell Physiol 2004;201:277-85.
22. Efimova T, LaCelle P, Welter JF, et al. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, API signal transduction pathway. J Biol Chem 1998;273:24387-95.
23. Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002;12:9-18.
24. Wang L, Liu F, Adamo ML. Cyclic AMP inhibits extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rapl. J Biol Chem 2001;276:37242-9.
25. Fujita T, Meguro T, Fukuyama R, et al. New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP. J Biol Chem 2002;277:22191-200.
26. Hecquet C, Lefevre G, Valtink M, et al. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner. Oncogene 2002;21:6101-12.
27. Zhang Z, Xin SM, Wu GX, et al. Endogenous δ-opioid and ORL1 receptors couple to phosphorylation and activation of p38 MAPK in NG108-15 cells and this is regulated by protein kinase A and protein kinase C. J Neurochem 1999;73:1502-9.
28. Zhen X, Uryu K, Wang HY, et al. D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells. Mol Pharmacol 1998;54:453-8.
29. Pomerance M, Abdullah HB, Kamerji S, et al. Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, racl, and reactive oxygen species. J Biol Chem 2000;275:40539-46.
30. Lee GR, Kim SN, Noguchi K, et al. Ala99ser mutation in RIα regulatory subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth. Mol Cell Biochem 1999;195:77-86.
31. McGahon A, Bissonnette R, Schmitt M, et al. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994;83:1179-87.
32. Gangemi RM, Santamaria B, Bargellesi A, et al. Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation. Int J Cancer 2000;85:527-33.
33. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
34. Tortora G, Clair T, Cho-Chung YS. An antisense oligodeoxynucleotide targeted against the type II β regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Proc Natl Acad Sci U S A 1990;87:705-8.
35. Yokozaki H, Budillon A, Tortora G, et al. An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res 1993;53:868-72.
36. Langeveld CH, Jongenelen CA, Theeuwes JW, et al. The antiproliferative effect of 8-chloro-adenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics. Biochem Pharmacol 1997;53:141-8.
37. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-31.
38. Kummer JL, Rao PK, Heidenreich KA. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 1997;272:20490-4.
39. Rosini P, De Chiara G, Lucibello M, et al. NGF withdrawal induces apoptosis in CESS B cell line through p38 MAPK activation and Bcl-2 phosphorylation. Biochem Biophys Res Commun 2000;278:753-9.
40. Huot J, Houle F, Rousseau S, et al. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol 1998;143:1361-73.
41. Zhuang S, Demirs JT, Kochevar IE. p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J Biol Chem 2000;275:25939-48.
42. Brenner B, Koppenhoefer U, Weinstock C, et al. Fasor ceramide-induced apoptosis is mediated by a Racl-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 1997;272:22173-81.
43. Willaime S, Vanhoutte P, Caboche J, et al. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 2001;13:2037-46.
44. Bulavin DV, Saito S, Hollander MC, et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 1999;18:6845-54.
45. Shimizu H, Banno Y, Sumi N, et al. Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. J Invest Dermatol 1999;112:769-74.
46. Assefa Z, Vantieghem A, Garmyn M, et al. p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis. J Biol Chem 2000;275:21416-21.